RIGL CIK: 1034842

Rigel Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
148
FY22:
118
FY23:
110
FY24:
161
FY25:
275
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.5
FY22:
−55.6
FY23:
−20.5
FY24:
24.2
FY25:
125
(positive)
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
−17.0
FY24:
28.5
FY25:
132
(positive)
Change from FY21 to FY25
millions USD
FY21:
−17.3
FY22:
−58.6
FY23:
−25.1
FY24:
18.4
FY25:
122
(positive)
Change from FY21 to FY25
millions USD
FY21:
−17.9
FY22:
−58.6
FY23:
−25.1
FY24:
17.5
FY25:
367

All amounts in millions USD Data sources:SEC EDGARTwelve Data